Cleared Traditional

K043491 - ENFANTTM

K043491 is an FDA 510(k) clearance for ENFANTTM, manufactured by Diopsys, Inc.. The device is a Class 2 Neurology device with product code GWE cleared through the Traditional 510(k) pathway after a 89-day FDA review.

K043491 · Diopsys, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2005
Decision
89d
Days
Class 2
Risk

K043491 is an FDA 510(k) clearance for the ENFANTTM. Classified as Stimulator, Photic, Evoked Response (product code GWE), Class II - Special Controls.

Submitted by Diopsys, Inc. (Pine Brook, US). The FDA issued a Cleared decision on March 16, 2005 after a review of 89 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Diopsys, Inc. devices

FDA 510(k) Submission Details - K043491

510(k) Number K043491 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 17, 2004
Decision Date March 16, 2005
Days to Decision 89 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
59d faster than avg
Panel avg: 148d · This submission: 89d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GWE Device Classification - Class 2, Special Controls

Product Code GWE Stimulator, Photic, Evoked Response
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWE Stimulator, Photic, Evoked Response

All 24
Devices cleared under the same product code (GWE) and FDA review panel - the closest regulatory comparables to K043491.
Vision Monitor - MonpackONE
K211643 · Metrovision · Jul 2021
Nurochek System
K200705 · Cryptych Pty, Ltd. · Apr 2020
Natus Photic Stimulator
K173936 · Natus Medical Incorporated Dba Excel-Tech Ltd. (Xltek) · Jun 2018
XLTEK LED GOGGLES, MODEL LED-01
K011794 · Excel Tech. , Ltd. · Oct 2001
DA VINCHI EMG/EP ISA1004EP
K001467 · Airsep Corp. · Aug 2000
EXCEL PHOTIC STIMULATOR, MODEL (XLPS-1)
K991903 · Excel Tech. , Ltd. · Aug 1999